← Back to Search
Development Of A Non‐toxic And Non‐denaturing Formulation Process For Encapsulation Of SDF‐1&agr; Into PLGA/PEG‐PLGA Nanoparticles To Achieve Sustained Release
Muhammad Haji Mansor, Mathie Najberg, Aurélien Contini, C. Alvarez-Lorenzo, E. Garcion, C. Jérôme, F. Boury
Published 2018 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Graphical abstract Figure. No caption available. ABSTRACT Chemokines are known to stimulate directed migration of cancer cells. Therefore, the strategy involving gradual chemokine release from polymeric vehicles for trapping cancer cells is of interest. In this work, the chemokine stromal cell‐derived factor‐1&agr; (SDF‐1&agr;) was encapsulated into nanoparticles composed of poly‐(lactic‐co‐glycolic acid) (PLGA) and a polyethylene glycol (PEG)‐PLGA co‐polymer to achieve sustained release. SDF‐1&agr;, and lysozyme as a model protein, were firstly precipitated to promote their stability upon encapsulation. A novel phase separation method utilising a non‐toxic solvent in the form of isosorbide dimethyl ether was developed for the individual encapsulation of SDF‐1&agr; and lysozyme precipitates. Uniform nanoparticles of 200–250 nm in size with spherical morphologies were successfully synthesised under mild formulation conditions and conveniently freeze‐dried in the presence of hydroxypropyl‐&bgr;‐cyclodextrin as a stabiliser. The effect of PLGA carboxylic acid terminal capping on protein encapsulation efficiency and release rate was also explored. Following optimisation, sustained release of SDF‐1&agr; was achieved over a period of 72 h. Importantly, the novel encapsulation process was found to induce negligible protein denaturation. The obtained SDF‐1&agr; nanocarriers may be subsequently incorporated within a hydrogel or other scaffolds to establish a chemokine concentration gradient for the trapping of glioblastoma cells.
This paper references
A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
J. Liu (2010)
Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage.
W. Abdelwahed (2006)
A. Spring (2005)
A Role for Protein Misfolding in Immunogenicity of Biopharmaceuticals*
C. Maas (2007)
Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell Uptake
F. De Jaeghere (2004)
Thermosensitive-polymer-coated magnetic nanoparticles: adsorption and desorption of bovine serum albumin.
N. Shamim (2006)
PLA-based biodegradable and tunable soft elastomers for biomedical applications.
A. Harrane (2011)
Organic solvents as vehicles for precipitating liquid embolics: a comparative angiotoxicity study with superselective injections of swine rete mirabile.
O. Dudeck (2006)
Freeze-drying of nanoparticles: Formulation
W. Abdelwahed (2006)
Co-delivery of VEGF and bFGF via a PLGA nanoparticle-modified BAM for effective contracture inhibition of regenerated bladder tissue in rabbits
Xincheng Jiang (2016)
Pharmacologically active microcarriers delivering BDNF within a hydrogel: Novel strategy for human bone marrow-derived stem cells neural/neuronal differentiation guidance and therapeutic secretome enhancement.
S. Kandalam (2017)
Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue
J. Deng (2011)
Optimization of protein encapsulation in PLGA nanoparticles
Tivadar Feczkó (2011)
Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres.
I. J. Castellanos (2005)
Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres.
J. Wang (2004)
Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma
Delphine Séhédic (2017)
Functional diversity of SDF-1 splicing variants
M. Janowski (2009)
Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches
杉山 立樹 (2007)
Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
Anshu Yang (2007)
New PLGA-P188-PLGA matrix enhances TGF-β3 release from pharmacologically active microcarriers and promotes chondrogenesis of mesenchymal stem cells.
M. Morille (2013)
ff ect of zeta potential on the properties of nano – drug delivery systems – a review ( Part 2 )
F. Zahir Honary (2013)
Recruitment of bone marrow-derived cells to periodontal tissue defects
Y. Kimura (2014)
Determination of End Point of Primary Drying in Freeze-Drying Process Control
S. M. Patel (2009)
A Role in Migration for the αvβ1 Integrin Expressed on Oligodendrocyte Precursors
R. Milner (1996)
Thermal and solution stability of lysozyme in the presence of sucrose, glucose, and trehalose.
S. James (2012)
Cytotoxicity and genotoxicity of lipid nanocapsules.
G. Le Roux (2017)
Freeze-drying of nanoparticles: formulation, process and storage considerations.
W. Abdelwahed (2006)
Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles.
U. Bilati (2005)
Study on CXCR4/SDF-1α axis in lymph node metastasis of cervical squamous cell carcinoma
J-P Zhang (2006)
Multi-block poloxamer surfactants suppress aggregation of denatured proteins.
D. Mustafi (2008)
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin.
J. Park (2009)
Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer.
H. Yoo (2001)
Sustained release of TGF-β1 from biodegradable microparticles prepared by a new green process in CO2 medium.
Amin Swed (2015)
Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers
B. Mukherjee (2008)
Surfactant-induced cell toxicity and cell lysis. A study using B16 melanoma cells.
M. Aránzazu Partearroyo (1990)
Accelerating protein release from microparticles for regenerative medicine applications
L. White (2013)
A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
B. Heurtault (2004)
PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.
R. Mainardes (2005)
Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide.
J. Lévesque (2003)
Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery.
M. Sameti (2003)
Encapsulation of Alpha-1 antitrypsin in PLGA nanoparticles: In Vitro characterization as an effective aerosol formulation in pulmonary diseases
N. Pirooznia (2012)
PLGA-based nanoparticles: an overview of biomedical applications.
F. Danhier (2012)
G.V.T.V. Weerasooriya (1824)
PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency.
Xiangrong Song (2008)
PEGylated insulin in PLGA microparticles
K. D. Hinds (2005)
Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.
A. Paillard-Giteau (2010)
Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
A. Sánchez (1999)
Preparation of polymeric particles in CO(2) medium using non-toxic solvents: formulation and comparisons with a phase separation method.
My-Kien Tran (2012)
Synthesis and rheological properties of polylactide/poly(ethylene glycol) multiblock copolymers.
F. Li (2005)
Compound Cytotoxicity Profiling Using Quantitative High-Throughput Screening
M. Xia (2008)
Freeze-Drying and Lyopreservation of Diblock and Triblock Poly(Lactic Acid)–Poly(Ethylene Oxide) (PLA–PEO) Copolymer Nanoparticles
F. De Jaeghere (2000)
Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres.
A. Giteau (2008)
Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model
北折 俊之 (2009)
Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant.
T. Morita (2000)
Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles.
U. Bilati (2005)
Structure-Immunogenicity Relationships of Therapeutic Proteins
Suzanne Hermeling (2004)
Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels
J. Liu (2007)
Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells.
Caroline Maupas (2011)
Hepatic Stellate Cells Promote Liver Metastasis of Colon Cancer Cells by the Action of SDF-1/CXCR4 Axis
R. Matsusue (2009)
CXCR4 EXPRESSION IS ELEVATED IN GLIOBLASTOMA MULTIFORME AND CORRELATES WITH AN INCREASE IN INTENSITY AND EXTENT OF PERITUMORAL T2‐WEIGHTED MAGNETIC RESONANCE IMAGING SIGNAL ABNORMALITIES
C. Stevenson (2008)
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A
L. Tang (2012)
Biodegradable Nanoparticles for Protein Delivery: Analysis of Preparation Conditions on Particle Morphology and Protein Loading, Activity and Sustained Release Properties
J. Coleman (2012)
A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
Einat Cohen-Sela (2009)
Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages.
N. Grabowski (2015)
Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells
M. Burger (2003)
Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres
Moraima Morales-Cruz (2012)
Protein-loaded PLGA–PEO blend nanoparticles: encapsulation, release and degradation characteristics
M. J. Santander-Ortega (2010)
A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization.
W. Abdelwahed (2006)
M. Voorneveld (2004)
PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis.
K. Hinds (2005)
CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma.
Bao-cheng Zhao (2011)
Collapse temperature of solutions important for lyopreservation of living cells at ambient temperature
G. Yang (2010)
Biocompatibility study of glycofurol in rat brains
A. Boongird (2011)
Carboxypeptidase M Expressed by Human Bone Marrow Cells Cleaves the C‐Terminal Lysine of Stromal Cell‐Derived Factor‐1α: Another Player in Hematopoietic Stem/Progenitor Cell Mobilization?
L. Marquez-Curtis (2008)
Differential processing of stromal-derived factor-1α and stromal-derived factor-1β explains functional diversity
M. D. L. L. Sierra (2004)
Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2)
S. Honary (2013)
This paper is referenced by
Encapsulation of Zn-DTPA into poly lactic-co-glycolic acid nanoparticles via a modified double emulsion method for extended release into lung fluid 1
E. Lai (2018)
Nanostructure-Enabled and Macromolecule-Grafted Surfaces for Biomedical Applications
Madeline Small (2018)
Mechanisms of endogenous repair failure during intervertebral disc degeneration.
K. Ma (2019)
Poloxamer 188 exerts a cryoprotective effect on rooster sperm and allows decreasing glycerol concentration in the freezing extender
M. Mehdipour (2020)
Aerogel sponges of silk fibroin, hyaluronic acid and heparin for soft tissue engineering: Composition-properties relationship.
Mathie Najberg (2020)
PEGylated polylactide (PLA) and poly (lactic-co-glycolic acid) (PLGA) copolymers for the design of drug delivery systems
D. R. Perinelli (2019)
Controllable fabrication of porous PLGA/PCL bilayer membrane for GTR using supercritical carbon dioxide foaming
C. Song (2019)
Biocompatibility and safety of insulin-loaded chitosan nanoparticles/ PLGA-PEG-PLGA hydrogel (ICNPH) delivered by subconjunctival injection in rats
Xianfang Rong (2019)
Fluorescent tamoxifen-encapsulated nanocapsules functionalized with folic acid for enhanced drug delivery toward breast cancer cell line MCF-7 and cancer cell imaging
Ehsan Nankali (2020)
Targeted drug delivery therapies inspired by natural taxes.
H. V. Nguyen (2020)
Characterization and Mathematical Modeling of Alginate/Chitosan-Based Nanoparticles Releasing the Chemokine CXCL12 to Attract Glioblastoma Cells
Suzanne Gascon (2020)
Development of a Sustained Release Nano-In-Gel Delivery System for the Chemotactic and Angiogenic Growth Factor Stromal-Derived Factor 1α
J. O’Dwyer (2020)
Recent advances in the formulation of PLGA microparticles for controlled drug delivery
Elena Lagreca (2020)
Reversing the Tumor Target: Establishment of a Tumor Trap
Mathie Najberg (2019)
Nanoformulations for glioblastoma multiforme: a new hope for treatment.
R. Ortiz (2019)
On briefing the surface modifications of polylactic acid: A scope for betterment of biomedical structures:
Guravtar Singh Mann (2019)
Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles
Enas M. Elmowafy (2019)